The Indian stock market is poised for a dynamic trading day following the recent initiation of Operation Sindoor aimed at dismantling terror camps in Pakistan. As the geopolitical landscape remains tense, investors are keenly observing potential market fluctuations. If you’re looking to make informed decisions in today’s trading session, here’s a roundup of key stocks and their recent performances.
Market Overview: Nifty and Sensex Updates
In the latest market close, the NSE Nifty 50 saw a modest rise, adding 35 points, or 0.14%, to finish at 24,414. Meanwhile, the BSE Sensex experienced an uptick of 106 points, or 0.13%, concluding the day at 80,747.
Key Stocks to Monitor on May 8, 2025
Coal India: Strong Profit Growth
Coal India reported an impressive 12.04% increase in its consolidated net profit for Q4 FY25, reaching ₹9,604.02 crore, up from ₹8,572.14 crore in the same quarter last year. However, the company’s revenue from operations dipped by 1% year-on-year to ₹37,824.54 crore, compared to ₹38,213.48 crore in Q4 FY24.
Dabur India: Profit Decline
In contrast, Dabur India experienced an 8.4% decline in consolidated net profit, which fell to ₹320.13 crore from ₹349.53 crore a year prior. The company’s revenue climbed slightly by 0.5% to ₹2,830 crore in Q4 FY25, compared to ₹2,814.6 crore in the same period of the previous year.
United Breweries: Robust Earnings Growth
United Breweries reported a notable 20.5% year-on-year increase in standalone net profit, reaching ₹97.4 crore for Q4 FY25, compared to ₹80.80 crore in the same quarter last year. The company also enjoyed a 8.9% rise in revenue from operations, totaling ₹2,321.3 crore versus ₹2,131.5 crore in the previous year.
Sapphire Foods: Flat Profit Amid Growth
Sapphire Foods maintained a steady profit of ₹2.02 crore in Q4 FY25, alongside a revenue increase of 12.61%, reaching ₹711.34 crore compared to ₹631.70 crore in Q4 FY24. This growth was primarily driven by robust performances from KFC India and Pizza Hut Sri Lanka.
Blue Star: Impressive Profit Surge
Blue Star showcased a 20.6% increase in net profit for Q4 FY25, achieving ₹193.6 crore, up from ₹160.5 crore a year earlier. Revenues from operations rose by 20.8% year-on-year, totaling ₹4,019 crore.
Tata Chemicals: Significant Loss Recovery
Tata Chemicals reported a net loss of ₹56 crore for Q4 FY25, a dramatic improvement from a loss of ₹850 crore in the same quarter last year. Revenue from operations increased slightly by 1% to ₹3,509 crore, compared to ₹3,475 crore previously. However, EBITDA suffered a 26% decline, dropping to ₹327 crore.
Lupin: New Product Launch in the US
Pharmaceutical giant Lupin has launched eslicarbazepine acetate tablets in the US after receiving approval from the US FDA. This new generic medication, available in various strengths, is designed for treating partial-onset seizures in patients aged four and older. Lupin is among the first companies to gain ANDA approval for this drug, granting them 180 days of shared generic exclusivity in the US market.
Upcoming Earnings Reports
Investors should keep an eye on earnings reports today from notable companies including Larsen & Toubro, Asian Paints, Titan Company, Britannia Industries, Biocon, and others. These reports will provide further insights into the financial health of key industry players for the last quarter of the financial year 2024-25.
Stay tuned for more updates as the market evolves throughout the day!
